SEC Info - Paratek Pharmaceuticals, Inc. - ‘S-4MEF’ on 10/27/14

SEC Info℠

Home

Help

Please Sign In

Paratek Pharmaceuticals, Inc. – ‘S-4MEF’ on 10/27/14 – ‘EX-23.1’

On: Monday, 10/27/14, at 8:58pm ET · Effective: 10/27/14 · Accession #: 1193125-14-383742 · File #s: 333-198464, 333-199624

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/27/14  Paratek Pharmaceuticals, Inc.     S-4MEF     10/27/14   12:143K                                   Donnelley … Solutions/FA

Registration of Additional Securities — Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4MEF      Registration of Additional Securities               HTML     44K 
 2: EX-5.1      Opinion re: Legality                                HTML     18K 
 3: EX-8.1      Opinion re: Tax Matters                             HTML     22K 
 4: EX-8.2      Opinion re: Tax Matters                             HTML     18K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML      7K 
 6: EX-23.2     Consent of Experts or Counsel                       HTML      8K 
 7: EX-99.1     Miscellaneous Exhibit                               HTML      7K 
 8: EX-99.2     Miscellaneous Exhibit                               HTML      8K 
 9: EX-99.3     Miscellaneous Exhibit                               HTML      8K 
10: EX-99.4     Miscellaneous Exhibit                               HTML      8K 
11: EX-99.5     Miscellaneous Exhibit                               HTML      8K 
12: EX-99.6     Miscellaneous Exhibit                               HTML      8K

EX-23.1 — Consent of Experts or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement on Form S-4 filed pursuant to Rule 462(b) of the Securities Act of 1933 of the reference to our firm under the caption “Experts” and to the incorporation by reference of our report dated March 14, 2014, with respect to the consolidated financial statements of Transcept Pharmaceuticals, Inc. included in Amendment No. 1 to the Registration Statement (Form S-4 No. 333-198464) and related Prospectus of Transcept Pharmaceuticals, Inc. for the registration of its common stock.

/s/ Ernst & Young LLP

Redwood City, California

October 27, 2014

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-4MEF’ Filing	Date	Other Filings

Filed on / Effective on:	10/27/14
	3/14/14	10-K
		List all Filings

↑Top